• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493918428270
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Death (1802); Ventricular Tachycardia (2132)
Event Date 07/11/2016
Event Type  Death  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
It was reported that the patient died.The patient was surviving with the left anterior descending artery (lad) the other 2 arteries were infracted and while opening lad the patient had cardiac arrest.The patient was referred for coronary artery bypass grafting as the physician considered this a complex case of multi vessel angioplasty; however the patient declined the referral and physician decided to perform percutaneous transluminal coronary angioplasty.Vascular access was obtained via the femoral artery.The 95% stenosed, 20mm in length, concentric, de novo target lesion was located in the mildly tortuous, mildly calcified, and 2.75mm in diameter mid left anterior descending (lad) artery.The physician planned to open the lad first, followed by right coronary artery (rca) and then in the left circumflex (lcx) artery.A 2.75x28mm promus element(tm) plus drug-eluting stent was advanced and deployed in the lesion.However, post stent deployment; there was slow flow, followed by no flow, and ventricular tachycardia (vt).After the patient became stable, it was decided to open other arteries later.After some time, the patient died in the intensive care unit (icu).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
linda leimer
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key5844507
MDR Text Key51108930
Report Number2134265-2016-06792
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Reporter Occupation Physician
Type of Report Initial
Report Date 07/11/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/03/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/10/2017
Device Model NumberH7493918428270
Device Catalogue Number39184-2827
Device Lot Number18325506
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/11/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/06/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age58 YR
-
-